Literature DB >> 1535230

A defective autologous mixed lymphocyte reaction in patients with idiopathic portal hypertension.

K Tokushige1, T Komatsu, K Ohzu, K Yamauchi, H Obata.   

Abstract

The aetiology of idiopathic portal hypertension or hepatoportal sclerosis is unknown. In view of the indirect evidence for underlying immunologic abnormalities 14 patients (all middle-aged females) were studied. Various auto-antibodies were demonstrated in seven patients and high levels of serum immunoglobulins, either IgG, IgM or IgA were present in ten patients. T cell responsiveness to stimulation with either autologous or allogeneic non-T cells was examined in nine of 14 idiopathic portal hypertension patients and compared with responsiveness in patients with posthepatitic cirrhosis and splenomegaly, and healthy controls. Patients with cirrhosis had levels of T cell responsiveness which were not significantly different from those in healthy controls in both autologous and allogeneic mixed lymphocyte reactions. A distinctly reduced autologous mixed lymphocyte reaction was observed in all idiopathic portal hypertension patients. These data indicate that, like many other autoimmune diseases, abnormal serological features and impaired autoreactive T cell responsiveness exist in patients with idiopathic portal hypertension.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1535230     DOI: 10.1111/j.1440-1746.1992.tb00978.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  3 in total

1.  Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Yogesh Kumar Chawla; Sanjay Saran Baijal; Radha Krishna Dhiman; Wasim Jafri; Laurentius A Lesmana; Debendranath Guha Mazumder; Masao Omata; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Praveen Sharma; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2007-09-11       Impact factor: 6.047

2.  Clinical features, serum interleukin-6, and interferon-gamma levels of 34 turkish patients with hepatoportal sclerosis.

Authors:  Aydin Seref Köksal; Seyfettin Köklü; Mehmet Ibiş; Mustafa Balci; Bahattin Ciçek; Nurgül Saşmaz; Burhan Sahin
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

Review 3.  Idiopathic noncirrhotic portal hypertension: current perspectives.

Authors:  Oliviero Riggio; Stefania Gioia; Ilaria Pentassuglio; Valeria Nicoletti; Michele Valente; Giulia d'Amati
Journal:  Hepat Med       Date:  2016-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.